CSET's Jacob Feldgoise and Hanna Dohmen outline China's market share gains in semiconductor manufacturing equipment, based on data from CSET ETO's updated Supply Chain Explorer.

Opposing narratives around AI for biotechnology raise the question: how are biotech researchers actually using AI in published research? CSET’s Steph Batalis, Catherine Aiken, and James Dunham explored this question by leveraging CSET’s merged academic corpus, enriched publication metadata, and research clusters.

Artificial intelligence is becoming more integrated into the sciences. One of the scientific fields experiencing this is computational biology, which uses computer modeling to understand biological mechanisms and systems. This blog post provides an understanding of important research trends in these subject areas, and how advancements in AI can improve the speed and efficiency of computational biology to improve human health and well-being.

Since 2022, U.S. export controls have restricted the highest-performing AI chips from being exported to China. The Biden administration likely did not intend to control CPUs (i.e., general-purpose processors) with these restrictions. However, CPUs are increasingly subject to export controls because chip designers are incorporating specialized elements for AI computation into CPUs. In this blog post, we discuss the implications of controlling AI-capable CPUs and make recommendations for the Bureau of Industry and Security (BIS) at the U.S. Department of Commerce.

Now that the first set of milestones has passed for the Biden administration’s October 2023 executive order on artificial intelligence, where do things stand for biotech? This blog post gives an overview of the most recent action items, with a recap of expert commentary from CSET’s June 2024 Webinar on the AIxBio Policy Landscape.

As the U.S. government considers banning genomics companies from China in the Biosecure Act, it opens a broader question of how the U.S. and other market economies should deal with China’s national champions. This blog post provides an overview of BGI and how China’s industrial policy impacts technology development.

As the U.S. government tightens its controls on China’s semiconductor ecosystem, a new dimension is increasingly worrying Congress: the open-source chip architecture known as RISC-V (pronounced “risk-five”). This blog post provides an introduction to the RISC-V architecture and an explanation of what policy-makers can do to address concerns about this open architecture.

This guide provides a run-down of CSET’s research since 2019 for first-time visitors and long-term fans alike. Quickly get up to speed on our “must-read” research and learn about how we organize our work.

On October 17, 2023, the Bureau of Industry and Security (BIS) issued an update to last year’s export controls on advanced computing, supercomputing and semiconductor manufacturing equipment. This blog post provides an overview of the updated advanced computing controls, analyzes more than 100 relevant chips, and discusses the licensing policies for the expanded chip restrictions and the increased country scope.

On October 30, 2023, the Biden administration released the Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (AI). This blog contemplates a potential lack of balance in the policy discussions between the restrictions that come with governance and the promise of opportunity unleashed by innovation. Is it possible to apply AI standards, governance, safeguards and protections in a manner that stimulates innovation, competitiveness and global leadership for the United States in AI?